SCHEMBL18200482

SCHEMBL18200482

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc(-c5ccc(-c6nc7ccccc7c7c6ccc6ccccc67)cc5)c4)cc3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ATM Q13315 1/20 0.50
LMNA P02545 3/20 0.39
MAPT P10636 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RECQL P46063 1/20 0.39
DHODH Q02127 2/20 0.39
ADORA2A P29274 1/20 0.39
NUDT1 P36639 1/20 0.39
WHR1 P49842 1/20 0.38
PDE10A Q9Y233 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200825 0.99 MEN1 (0.49) MEN1KMT2AATMLMNAMAPT
SCHEMBL18200509 0.97 MEN1 (0.47) MEN1KMT2AATMLMNAMAPT
SCHEMBL18200599 0.94 NUDT1 (0.42) MEN1KMT2AATMLMNAMAPT
SCHEMBL18200471 0.94 MEN1 (0.55) MEN1KMT2AATMLMNAMAPT
SCHEMBL18200522 0.94 MEN1 (0.55) MEN1KMT2AATMLMNAMAPT
SCHEMBL18201118 0.94 MEN1 (0.53) MEN1KMT2AATMLMNAMAPT
SCHEMBL18200591 0.94 MEN1 (0.53) MEN1KMT2AATMLMNAMAPT
SCHEMBL18200632 0.94 MEN1 (0.44) MEN1KMT2AATMLMNAMAPT
SCHEMBL18200938 0.94 MEN1 (0.44) MEN1KMT2AATMLMNAMAPT
SCHEMBL18201140 0.94 MEN1 (0.44) MEN1KMT2AATMLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MEN1 1750/4885KMT2A 1104/4885ATM 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.